Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qudexy XR in Refractory Partial-Onset Seizures (OLE)
NCT01191086Phase 3Completed
- Sponsor
- Upsher-Smith Laboratories
- Start
- Oct 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of topiramate in focal epilepsy, sponsored by Upsher-Smith Laboratories. Started Oct 2010; status: completed.
02
Drugs
topiramate
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT01191086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191086.